The Medtech & Pharma Platform (MPP) Association held its annual General Assembly meeting on 5 April 2023.
The MPP Secretariat presented an overview of the association activities in 2022 and an outlook for 2023 to the members. The MPP President underlined the progress achieved since the creation of the association, which is now a recognized stakeholder at the European level. She thanked the members for their support, which has enabled the MPP to continuously expand its activities and presence.
The General Assembly reelected the following candidates for the MPP Board of Directors: Shayesteh Fürst-Ladani (SFL), Stephan Affolter (Ypsomed), Daniel Delfosse (Swiss Medtech), Stephanie Horn (Roche) and Manfred Mäder (Novartis). Shayesteh Fürst-Ladani was re-elected as President.
The MPP will pursue its work in 2023 to foster synergies between the pharma, medtech and tech sectors and progress towards a balanced regulatory framework for combined products in Europe.
